Circulating microRNAs: Next-generation biomarkers for early lung cancer detection

Research output: Contribution to journalArticlepeer-review


Early diagnosis of lung cancer by low-dose computed tomography is an effective strategy to reduce cancer mortality in high-risk individuals. However, recruitment of at-risk individuals with asymptomatic lung cancer still remains challenging. We developed a minimal invasive serum test, based on the detection of circulating microRNAs, which can identify at-risk individuals with asymptomatic early stage nonsmall cell lung carcinomas with 80% accuracy. Copyright:

Original languageEnglish
Article number246
Issue number1
Publication statusPublished - Mar 6 2012

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Circulating microRNAs: Next-generation biomarkers for early lung cancer detection'. Together they form a unique fingerprint.

Cite this